How Regulations Shape and Constrain Medical Practice
How Regulations Shape and Constrain Medical Practice
Stanford Health Policy's Michelle Mello discusses how the law, artificial intelligence, and the COVID-19 pandemic have shaped health care in this Q&A with The Regulatory Review.
In a conversation with The Regulatory Review—published by the Penn Program on Regulation—SHP’s Michelle Mello shares her perspective about the forces that are shaping the practice of medicine, including the law, security, and artificial intelligence.
The U.S. health-care industry and systems have seen significant shifts in regulatory requirements following the pandemic, as well as an increased focus on the roles that AI and for-profit actors play in the practice of medicine. In this Q&A, the professor of health policy and of law, calls attention to the implications of a regulatory landscape that allows too much space for defensive medicine and investors with profit motives.
“The single greatest threat I perceive is the march of highly profit-oriented owners and investors into health care provision,” Mello says. “Private equity has a time and a place, but I am very skeptical that it is commensurate with providing the space for high-quality, compassionate care in facilities like nursing homes and hospice.”
